BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhou S, Wei J, Wang Y, Liu X. Cisplatin resistance-associated circRNA_101237 serves as a prognostic biomarker in hepatocellular carcinoma. Exp Ther Med 2020;19:2733-40. [PMID: 32226487 DOI: 10.3892/etm.2020.8526] [Cited by in Crossref: 8] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhang ZY, Gao XH, Ma MY, Zhao CL, Zhang YL, Guo SS. CircRNA_101237 promotes NSCLC progression via the miRNA-490-3p/MAPK1 axis. Sci Rep 2020;10:9024. [PMID: 32494004 DOI: 10.1038/s41598-020-65920-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
2 Louis C, Leclerc D, Coulouarn C. Emerging roles of circular RNAs in liver cancer. JHEP Rep 2022;4:100413. [PMID: 35036887 DOI: 10.1016/j.jhepr.2021.100413] [Reference Citation Analysis]
3 Meng H, Niu R, Huang C, Li J. Circular RNA as a Novel Biomarker and Therapeutic Target for HCC. Cells 2022;11:1948. [PMID: 35741077 DOI: 10.3390/cells11121948] [Reference Citation Analysis]
4 Yan J, Shao Y, Lu H, Ye Q, Ye G, Guo J. Hsa_circ_0001020 Serves as a Potential Biomarker for Gastric Cancer Screening and Prognosis. Dig Dis Sci 2021. [PMID: 34424459 DOI: 10.1007/s10620-021-07211-y] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Long N, Xu X, Lin H, Lv Y, Zou S, Cao H, Chen X, Zhao Y, Qi X, Yang H, Liu J, Chu L. Circular RNA circPOSTN promotes neovascularization by regulating miR-219a-2-3p/STC1 axis and stimulating the secretion of VEGFA in glioblastoma. Cell Death Discov 2022;8:349. [PMID: 35927233 DOI: 10.1038/s41420-022-01136-9] [Reference Citation Analysis]
6 Xiong D, He R, Dang Y, Wu H, Feng Z, Chen G. The Latest Overview of circRNA in the Progression, Diagnosis, Prognosis, Treatment, and Drug Resistance of Hepatocellular Carcinoma. Front Oncol 2020;10:608257. [PMID: 33680930 DOI: 10.3389/fonc.2020.608257] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Xi SJ, Cai WQ, Wang QQ, Peng XC. Role of circular RNAs in gastrointestinal tumors and drug resistance. World J Clin Cases 2021; 9(34): 10400-10417 [PMID: 35004973 DOI: 10.12998/wjcc.v9.i34.10400] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Liu X, Gao L, Shi S, Yang Y. Clinical Significance of has_circ_0055625 in Colon Cancer Patients Undergoing FOLFOX Chemotherapy Treatment. Int J Gen Med 2021;14:221-7. [PMID: 33519228 DOI: 10.2147/IJGM.S290440] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Fan W, Chen L, Wu X, Zhang T. Circ_0031242 Silencing Mitigates the Progression and Drug Resistance in DDP-Resistant Hepatoma Cells by the miR-924/POU3F2 Axis. Cancer Manag Res 2021;13:743-55. [PMID: 33531841 DOI: 10.2147/CMAR.S272851] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Rajappa A, Banerjee S, Sharma V, Khandelia P. Circular RNAs: Emerging Role in Cancer Diagnostics and Therapeutics. Front Mol Biosci 2020;7:577938. [PMID: 33195421 DOI: 10.3389/fmolb.2020.577938] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
11 Liu Y, Wang L, Liu W. Roles of circRNAs in the Tumorigenesis and Metastasis of HCC: A Mini Review. Cancer Manag Res 2022;14:1847-56. [PMID: 35668744 DOI: 10.2147/CMAR.S362594] [Reference Citation Analysis]
12 Li W, Ma Q, Liu Q, Yan P, Wang X, Jia X. Circ-VPS18 Knockdown Enhances TMZ Sensitivity and Inhibits Glioma Progression by MiR-370/RUNX1 Axis. J Mol Neurosci 2021;71:1234-44. [PMID: 33188501 DOI: 10.1007/s12031-020-01749-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Qin S, Mao Y, Chen X, Xiao J, Qin Y, Zhao L. The functional roles, cross-talk and clinical implications of m6A modification and circRNA in hepatocellular carcinoma. Int J Biol Sci 2021;17:3059-79. [PMID: 34421350 DOI: 10.7150/ijbs.62767] [Reference Citation Analysis]
14 Mu Q, Lv Y, Luo C, Liu X, Huang C, Xiu Y, Tang L. Research Progress on the Functions and Mechanism of circRNA in Cisplatin Resistance in Tumors. Front Pharmacol 2021;12:709324. [PMID: 34566636 DOI: 10.3389/fphar.2021.709324] [Reference Citation Analysis]
15 Liao R, Liu L, Zhou J, Wei X, Huang P. Current Molecular Biology and Therapeutic Strategy Status and Prospects for circRNAs in HBV-Associated Hepatocellular Carcinoma. Front Oncol 2021;11:697747. [PMID: 34277444 DOI: 10.3389/fonc.2021.697747] [Reference Citation Analysis]
16 Ely A, Bloom K, Maepa MB, Arbuthnot P. Recent Update on the Role of Circular RNAs in Hepatocellular Carcinoma. J Hepatocell Carcinoma 2021;8:1-17. [PMID: 33542907 DOI: 10.2147/JHC.S268291] [Reference Citation Analysis]
17 Sukowati CHC, Cabral LKD, Tiribelli C, Pascut D. Circulating Long and Circular Noncoding RNA as Non-Invasive Diagnostic Tools of Hepatocellular Carcinoma. Biomedicines 2021;9:90. [PMID: 33477833 DOI: 10.3390/biomedicines9010090] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]